Ethic Inc. Buys 2,781 Shares of Stryker Corporation $SYK

Ethic Inc. increased its stake in Stryker Corporation (NYSE:SYK) by 5.4% during the fourth quarter, Holdings Channel.com reports. The fund owned 53,906 shares of the medical technology company’s stock after buying an additional 2,781 shares during the period. Ethic Inc.’s holdings in Stryker were worth $18,946,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. United Financial Planning Group LLC acquired a new position in shares of Stryker in the 3rd quarter worth approximately $27,000. CGC Financial Services LLC acquired a new stake in shares of Stryker during the fourth quarter worth $29,000. Strive Asset Management LLC bought a new position in Stryker during the third quarter worth $30,000. ANTIPODES PARTNERS Ltd acquired a new position in Stryker in the third quarter valued at $34,000. Finally, Copia Wealth Management lifted its holdings in Stryker by 181.6% in the third quarter. Copia Wealth Management now owns 107 shares of the medical technology company’s stock valued at $40,000 after buying an additional 69 shares during the period. Institutional investors and hedge funds own 77.09% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on SYK. Weiss Ratings downgraded Stryker from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday. Wall Street Zen upgraded Stryker from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Citigroup lowered their target price on Stryker from $420.00 to $385.00 and set a “buy” rating for the company in a report on Tuesday, April 7th. UBS Group dropped their price target on Stryker from $400.00 to $380.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 17th. Finally, Jefferies Financial Group restated a “buy” rating and set a $465.00 price target on shares of Stryker in a report on Wednesday, March 4th. Sixteen analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Stryker has an average rating of “Moderate Buy” and an average target price of $395.48.

Stryker Price Performance

SYK stock opened at $285.49 on Friday. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25. The company’s 50-day moving average is $340.37 and its 200-day moving average is $355.17. The stock has a market capitalization of $109.34 billion, a PE ratio of 33.04, a price-to-earnings-growth ratio of 1.85 and a beta of 0.80. Stryker Corporation has a 1 year low of $284.95 and a 1 year high of $404.87.

Stryker (NYSE:SYK) last posted its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The firm had revenue of $6.02 billion for the quarter, compared to analyst estimates of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.The firm’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period last year, the company posted $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Equities research analysts expect that Stryker Corporation will post 14.98 EPS for the current fiscal year.

Stryker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date of this dividend is Tuesday, June 30th. Stryker’s dividend payout ratio is presently 40.74%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.